Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Praecis Pharmaceuticals Inc (PRCS) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Praecis Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1033025.
Total stock buying since 2006: $0.
Total stock sales since 2006: $0.
Total stock option exercises since 2006: $167,846.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2006 | 0 | $0 | 0 | $0 | 126,200 | $167,846 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2006-09 | 0 | $0 | 0 | $0 | 24,200 | $32,186 |
| 2006-07 | 0 | $0 | 0 | $0 | 92,500 | $123,025 |
| 2006-03 | 0 | $0 | 0 | $0 | 9,500 | $12,635 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-09-01 | Mclaughlin Kevin F (President and CEO) | Option Ex | 24,200 | 1.33 | 32,186 |
| 2006-07-10 | Gefter Malcolm L Phd (Chairman and CSO) | Option Ex | 92,500 | 1.33 | 123,025 |
| 2006-03-13 | Gefter Malcolm L Phd (Director) | Option Ex | 9,500 | 1.33 | 12,635 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRCS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Praecis Pharmaceuticals Inc (symbol PRCS, CIK number 1033025) see the Securities and Exchange Commission (SEC) website.